APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchPediatric Vaccines Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Pediatric Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Vaccines Segment by Company

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

S K Chemicals

Serum Institute of India

Sinovac Biotech

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Takeda Pharmaceutical

Janssen

Pediatric Vaccines Segment by Type

Meningococcal Diseases

Influenza

Hepatitis

Pneumococcal Diseases

Diphtheria

Others

Pediatric Vaccines Segment by Application

Infant

Newborn

Dolescent

Child

Pediatric Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pediatric Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pediatric Vaccines Industry Trends Table 2. Pediatric Vaccines Industry Drivers Table 3. Pediatric Vaccines Industry Opportunities and Challenges Table 4. Pediatric Vaccines Industry Restraints Table 5. Global Pediatric Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pediatric Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pediatric Vaccines Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Pediatric Vaccines Sales Market Share by Manufacturers Table 9. Global Pediatric Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pediatric Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pediatric Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pediatric Vaccines Manufacturers, Product Type & Application Table 13. Global Pediatric Vaccines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Meningococcal Diseases Table 17. Major Manufacturers of Influenza Table 18. Major Manufacturers of Hepatitis Table 19. Major Manufacturers of Pneumococcal Diseases Table 20. Major Manufacturers of Diphtheria Table 21. Major Manufacturers of Others Table 22. Global Pediatric Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 23. Global Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 24. Global Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 25. Global Pediatric Vaccines Sales Market Share by Type (2021-2026) Table 26. Global Pediatric Vaccines Sales Market Share by Type (2027-2032) Table 27. Global Pediatric Vaccines Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 28. Global Pediatric Vaccines Revenue by Type (2021-2026) & (W Units) Table 29. Global Pediatric Vaccines Revenue by Type (2027-2032) & (W Units) Table 30. Global Pediatric Vaccines Revenue Market Share by Type (2021-2026) Table 31. Global Pediatric Vaccines Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Infant Table 33. Major Manufacturers of Newborn Table 34. Major Manufacturers of Dolescent Table 35. Major Manufacturers of Child Table 36. Global Pediatric Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 38. Global Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 39. Global Pediatric Vaccines Sales Market Share by Application (2021-2026) Table 40. Global Pediatric Vaccines Sales Market Share by Application (2027-2032) Table 41. Global Pediatric Vaccines Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Pediatric Vaccines Revenue by Application (2021-2026) & (W Units) Table 43. Global Pediatric Vaccines Revenue by Application (2027-2032) & (W Units) Table 44. Global Pediatric Vaccines Revenue Market Share by Application (2021-2026) Table 45. Global Pediatric Vaccines Revenue Market Share by Application (2027-2032) Table 46. Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Pediatric Vaccines Sales by Region (2021-2026) & (W Units) Table 48. Global Pediatric Vaccines Sales Market Share by Region (2021-2026) Table 49. Global Pediatric Vaccines Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Pediatric Vaccines Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 53. North America Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 54. Europe Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 56. Europe Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 63. Global Pediatric Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Pediatric Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Pediatric Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Pediatric Vaccines Revenue Market Share by Region (2021-2026) Table 67. Global Pediatric Vaccines Revenue Market Share by Region (2027-2032) Table 68. Bavarian Nordic Company Information Table 69. Bavarian Nordic Business Overview Table 70. Bavarian Nordic Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bavarian Nordic Pediatric Vaccines Product Portfolio Table 72. Bavarian Nordic Recent Development Table 73. Bharat Biotech Company Information Table 74. Bharat Biotech Business Overview Table 75. Bharat Biotech Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Bharat Biotech Pediatric Vaccines Product Portfolio Table 77. Bharat Biotech Recent Development Table 78. Crucell Company Information Table 79. Crucell Business Overview Table 80. Crucell Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Crucell Pediatric Vaccines Product Portfolio Table 82. Crucell Recent Development Table 83. Dynavax Company Information Table 84. Dynavax Business Overview Table 85. Dynavax Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Dynavax Pediatric Vaccines Product Portfolio Table 87. Dynavax Recent Development Table 88. LG Life Sciences Company Information Table 89. LG Life Sciences Business Overview Table 90. LG Life Sciences Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. LG Life Sciences Pediatric Vaccines Product Portfolio Table 92. LG Life Sciences Recent Development Table 93. Lupin Company Information Table 94. Lupin Business Overview Table 95. Lupin Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Lupin Pediatric Vaccines Product Portfolio Table 97. Lupin Recent Development Table 98. Mitsubishi Tanabe Pharma Company Information Table 99. Mitsubishi Tanabe Pharma Business Overview Table 100. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio Table 102. Mitsubishi Tanabe Pharma Recent Development Table 103. S K Chemicals Company Information Table 104. S K Chemicals Business Overview Table 105. S K Chemicals Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. S K Chemicals Pediatric Vaccines Product Portfolio Table 107. S K Chemicals Recent Development Table 108. Serum Institute of India Company Information Table 109. Serum Institute of India Business Overview Table 110. Serum Institute of India Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Serum Institute of India Pediatric Vaccines Product Portfolio Table 112. Serum Institute of India Recent Development Table 113. Sinovac Biotech Company Information Table 114. Sinovac Biotech Business Overview Table 115. Sinovac Biotech Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sinovac Biotech Pediatric Vaccines Product Portfolio Table 117. Sinovac Biotech Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. AstraZeneca Pediatric Vaccines Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Baxter Company Information Table 124. Baxter Business Overview Table 125. Baxter Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Baxter Pediatric Vaccines Product Portfolio Table 127. Baxter Recent Development Table 128. GlaxoSmithKline Company Information Table 129. GlaxoSmithKline Business Overview Table 130. GlaxoSmithKline Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. GlaxoSmithKline Pediatric Vaccines Product Portfolio Table 132. GlaxoSmithKline Recent Development Table 133. Pfizer Company Information Table 134. Pfizer Business Overview Table 135. Pfizer Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Pfizer Pediatric Vaccines Product Portfolio Table 137. Pfizer Recent Development Table 138. Merck Company Information Table 139. Merck Business Overview Table 140. Merck Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Merck Pediatric Vaccines Product Portfolio Table 142. Merck Recent Development Table 143. Novartis Company Information Table 144. Novartis Business Overview Table 145. Novartis Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Novartis Pediatric Vaccines Product Portfolio Table 147. Novartis Recent Development Table 148. Sanofi Company Information Table 149. Sanofi Business Overview Table 150. Sanofi Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Sanofi Pediatric Vaccines Product Portfolio Table 152. Sanofi Recent Development Table 153. Shenzhen Kangtai Biological Products Company Information Table 154. Shenzhen Kangtai Biological Products Business Overview Table 155. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio Table 157. Shenzhen Kangtai Biological Products Recent Development Table 158. Takeda Pharmaceutical Company Information Table 159. Takeda Pharmaceutical Business Overview Table 160. Takeda Pharmaceutical Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Takeda Pharmaceutical Pediatric Vaccines Product Portfolio Table 162. Takeda Pharmaceutical Recent Development Table 163. Janssen Company Information Table 164. Janssen Business Overview Table 165. Janssen Pediatric Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Janssen Pediatric Vaccines Product Portfolio Table 167. Janssen Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Pediatric Vaccines Distributors List Table 171. Pediatric Vaccines Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pediatric Vaccines Product Image Figure 2. Global Pediatric Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Pediatric Vaccines Sales (2021-2032) & (W Units) Figure 5. Global Pediatric Vaccines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Meningococcal Diseases Image Figure 9. Influenza Image Figure 10. Hepatitis Image Figure 11. Pneumococcal Diseases Image Figure 12. Diphtheria Image Figure 13. Others Image Figure 14. Global Pediatric Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Pediatric Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Pediatric Vaccines Sales Market Share by Type (2021-2032) Figure 17. Global Pediatric Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 18. Global Pediatric Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pediatric Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Infant Image Figure 21. Newborn Image Figure 22. Dolescent Image Figure 23. Child Image Figure 24. Global Pediatric Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Pediatric Vaccines Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pediatric Vaccines Sales Market Share by Application (2021-2032) Figure 27. Global Pediatric Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Pediatric Vaccines Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Pediatric Vaccines Revenue Market Share by Application (2021-2032) Figure 30. North America Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 32. U.S. Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 37. Germany Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 44. China Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 52. Brazil Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Pediatric Vaccines Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Pediatric Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Pediatric Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Figure 63. North America Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Figure 65. Europe Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Pediatric Vaccines Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Pediatric Vaccines Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Pediatric Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Meningococcal Diseases
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Diphtheria
  • Others
Applications
  • Infant
  • Newborn
  • Dolescent
  • Child
Companies covered
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Takeda Pharmaceutical
  • Janssen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pediatric Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pediatric Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pediatric Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pediatric Vaccines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pediatric Vaccines Market Dynamics
  1. 2.1 Pediatric Vaccines Industry Trends
  2. 2.2 Pediatric Vaccines Industry Drivers
  3. 2.3 Pediatric Vaccines Industry Opportunities and Challenges
  4. 2.4 Pediatric Vaccines Industry Restraints
3 Pediatric Vaccines Market by Manufacturers
  1. 3.1 Global Pediatric Vaccines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pediatric Vaccines Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Vaccines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pediatric Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pediatric Vaccines Manufacturers, Product Type & Application
  7. 3.7 Global Pediatric Vaccines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pediatric Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pediatric Vaccines Tier 1, Tier 2, and Tier 3
4 Pediatric Vaccines Market by Type
  1. 4.1 Pediatric Vaccines Type Introduction
  2. 4.1.1 Meningococcal Diseases
  3. 4.1.2 Influenza
  4. 4.1.3 Hepatitis
  5. 4.1.4 Pneumococcal Diseases
  6. 4.1.5 Diphtheria
  7. 4.1.6 Others
  8. 4.2 Global Pediatric Vaccines Sales by Type
  9. 4.2.1 Global Pediatric Vaccines Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Pediatric Vaccines Sales by Type (2021-2032)
  11. 4.2.3 Global Pediatric Vaccines Sales Market Share by Type (2021-2032)
  12. 4.3 Global Pediatric Vaccines Revenue by Type
  13. 4.3.1 Global Pediatric Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Pediatric Vaccines Revenue by Type (2021-2032)
  15. 4.3.3 Global Pediatric Vaccines Revenue Market Share by Type (2021-2032)
5 Pediatric Vaccines Market by Application
  1. 5.1 Pediatric Vaccines Application Introduction
  2. 5.1.1 Infant
  3. 5.1.2 Newborn
  4. 5.1.3 Dolescent
  5. 5.1.4 Child
  6. 5.2 Global Pediatric Vaccines Sales by Application
  7. 5.2.1 Global Pediatric Vaccines Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pediatric Vaccines Sales by Application (2021-2032)
  9. 5.2.3 Global Pediatric Vaccines Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pediatric Vaccines Revenue by Application
  11. 5.3.1 Global Pediatric Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pediatric Vaccines Revenue by Application (2021-2032)
  13. 5.3.3 Global Pediatric Vaccines Revenue Market Share by Application (2021-2032)
6 Global Pediatric Vaccines Sales by Region
  1. 6.1 Global Pediatric Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Vaccines Sales by Region (2021-2026)
  4. 6.2.2 Global Pediatric Vaccines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pediatric Vaccines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pediatric Vaccines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pediatric Vaccines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pediatric Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pediatric Vaccines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pediatric Vaccines Revenue by Region
  1. 7.1 Global Pediatric Vaccines Revenue by Region
  2. 7.1.1 Global Pediatric Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pediatric Vaccines Revenue by Region (2021-2026)
  4. 7.1.3 Global Pediatric Vaccines Revenue by Region (2027-2032)
  5. 7.1.4 Global Pediatric Vaccines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pediatric Vaccines Revenue (2021-2032)
  8. 7.2.2 North America Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pediatric Vaccines Revenue (2021-2032)
  11. 7.3.2 Europe Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pediatric Vaccines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pediatric Vaccines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pediatric Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bavarian Nordic
  2. 8.1.1 Bavarian Nordic Company Information
  3. 8.1.2 Bavarian Nordic Business Overview
  4. 8.1.3 Bavarian Nordic Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
  6. 8.1.5 Bavarian Nordic Recent Developments
  7. 8.2 Bharat Biotech
  8. 8.2.1 Bharat Biotech Company Information
  9. 8.2.2 Bharat Biotech Business Overview
  10. 8.2.3 Bharat Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
  12. 8.2.5 Bharat Biotech Recent Developments
  13. 8.3 Crucell
  14. 8.3.1 Crucell Company Information
  15. 8.3.2 Crucell Business Overview
  16. 8.3.3 Crucell Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Crucell Pediatric Vaccines Product Portfolio
  18. 8.3.5 Crucell Recent Developments
  19. 8.4 Dynavax
  20. 8.4.1 Dynavax Company Information
  21. 8.4.2 Dynavax Business Overview
  22. 8.4.3 Dynavax Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dynavax Pediatric Vaccines Product Portfolio
  24. 8.4.5 Dynavax Recent Developments
  25. 8.5 LG Life Sciences
  26. 8.5.1 LG Life Sciences Company Information
  27. 8.5.2 LG Life Sciences Business Overview
  28. 8.5.3 LG Life Sciences Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
  30. 8.5.5 LG Life Sciences Recent Developments
  31. 8.6 Lupin
  32. 8.6.1 Lupin Company Information
  33. 8.6.2 Lupin Business Overview
  34. 8.6.3 Lupin Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lupin Pediatric Vaccines Product Portfolio
  36. 8.6.5 Lupin Recent Developments
  37. 8.7 Mitsubishi Tanabe Pharma
  38. 8.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 8.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 8.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
  42. 8.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 8.8 S K Chemicals
  44. 8.8.1 S K Chemicals Company Information
  45. 8.8.2 S K Chemicals Business Overview
  46. 8.8.3 S K Chemicals Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
  48. 8.8.5 S K Chemicals Recent Developments
  49. 8.9 Serum Institute of India
  50. 8.9.1 Serum Institute of India Company Information
  51. 8.9.2 Serum Institute of India Business Overview
  52. 8.9.3 Serum Institute of India Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
  54. 8.9.5 Serum Institute of India Recent Developments
  55. 8.10 Sinovac Biotech
  56. 8.10.1 Sinovac Biotech Company Information
  57. 8.10.2 Sinovac Biotech Business Overview
  58. 8.10.3 Sinovac Biotech Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
  60. 8.10.5 Sinovac Biotech Recent Developments
  61. 8.11 AstraZeneca
  62. 8.11.1 AstraZeneca Company Information
  63. 8.11.2 AstraZeneca Business Overview
  64. 8.11.3 AstraZeneca Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
  66. 8.11.5 AstraZeneca Recent Developments
  67. 8.12 Baxter
  68. 8.12.1 Baxter Company Information
  69. 8.12.2 Baxter Business Overview
  70. 8.12.3 Baxter Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Baxter Pediatric Vaccines Product Portfolio
  72. 8.12.5 Baxter Recent Developments
  73. 8.13 GlaxoSmithKline
  74. 8.13.1 GlaxoSmithKline Company Information
  75. 8.13.2 GlaxoSmithKline Business Overview
  76. 8.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
  78. 8.13.5 GlaxoSmithKline Recent Developments
  79. 8.14 Pfizer
  80. 8.14.1 Pfizer Company Information
  81. 8.14.2 Pfizer Business Overview
  82. 8.14.3 Pfizer Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Pfizer Pediatric Vaccines Product Portfolio
  84. 8.14.5 Pfizer Recent Developments
  85. 8.15 Merck
  86. 8.15.1 Merck Company Information
  87. 8.15.2 Merck Business Overview
  88. 8.15.3 Merck Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Merck Pediatric Vaccines Product Portfolio
  90. 8.15.5 Merck Recent Developments
  91. 8.16 Novartis
  92. 8.16.1 Novartis Company Information
  93. 8.16.2 Novartis Business Overview
  94. 8.16.3 Novartis Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Novartis Pediatric Vaccines Product Portfolio
  96. 8.16.5 Novartis Recent Developments
  97. 8.17 Sanofi
  98. 8.17.1 Sanofi Company Information
  99. 8.17.2 Sanofi Business Overview
  100. 8.17.3 Sanofi Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Sanofi Pediatric Vaccines Product Portfolio
  102. 8.17.5 Sanofi Recent Developments
  103. 8.18 Shenzhen Kangtai Biological Products
  104. 8.18.1 Shenzhen Kangtai Biological Products Company Information
  105. 8.18.2 Shenzhen Kangtai Biological Products Business Overview
  106. 8.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
  108. 8.18.5 Shenzhen Kangtai Biological Products Recent Developments
  109. 8.19 Takeda Pharmaceutical
  110. 8.19.1 Takeda Pharmaceutical Company Information
  111. 8.19.2 Takeda Pharmaceutical Business Overview
  112. 8.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
  114. 8.19.5 Takeda Pharmaceutical Recent Developments
  115. 8.20 Janssen
  116. 8.20.1 Janssen Company Information
  117. 8.20.2 Janssen Business Overview
  118. 8.20.3 Janssen Pediatric Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Janssen Pediatric Vaccines Product Portfolio
  120. 8.20.5 Janssen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Vaccines Value Chain Analysis
  2. 9.1.1 Pediatric Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Vaccines Production Mode & Process
  6. 9.2 Pediatric Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Vaccines Distributors
  9. 9.2.3 Pediatric Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst